Hepatocellular Carcinoma: Surgical Management and Evolving Therapies
- PMID: 39212922
- DOI: 10.1007/978-3-031-61238-1_10
Hepatocellular Carcinoma: Surgical Management and Evolving Therapies
Abstract
Hepatocellular carcinoma (HCC) is the fifth most common cancer in men and the eighth most common cancer in women worldwide. It is also the second leading cause of cancer death worldwide, with 780,000 deaths in 2018. Seventy-two percent of HCC cases occur in Asia, 10% in Europe, 8% in Africa, 5% in North America, and 5% in Latin America (Singal et al. in J Hepatol 72(2):250-261, 2020 [1]).
© 2024. The Author(s), under exclusive license to Springer Nature Switzerland AG.
References
-
- Key statistics about liver cancer (2023). https://www.cancer.org/cancer/types/liver-cancer/about/what-is-key-stati...
-
- El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340(10):745–750. https://doi.org/10.1056/NEJM199903113401001 - DOI - PubMed
-
- Suriawinata AA, Thung SN (2002) Malignant liver tumors. Clin Liver Dis 6(2):527–554, ix. http://www.ncbi.nlm.nih.gov/pubmed/12122869
-
- Proneth A, Zeman F, Schlitt HJ, Schnitzbauer AA (2014) Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible? A systematic review and metaanalysis. Ann Surg Oncol 21(9):3096–3107. https://doi.org/10.1245/s10434-014-3808-1 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
